Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
Tech Waystar boosts 2026 outlook as AI solutions gain tractionBy Healthcare Propulsion StaffJuly 30, 20260 Healthcare payment software maker Waystar outperformed analysts’ estimates in the second quarter, with executives touting broader deployments of its artificial…